BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11441004)

  • 1. Vaccinia topoisomerase mutants illuminate conformational changes during closure of the protein clamp and assembly of a functional active site.
    Krogh BO; Shuman S
    J Biol Chem; 2001 Sep; 276(39):36091-9. PubMed ID: 11441004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia topoisomerase mutants illuminate roles for Phe59, Gly73, Gln69 and Phe215.
    Tian L; Shuman S
    Virology; 2007 Mar; 359(2):466-76. PubMed ID: 17059840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.
    Yakovleva L; Chen S; Hecht SM; Shuman S
    J Biol Chem; 2008 Jun; 283(23):16093-103. PubMed ID: 18367446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.
    Wittschieben J; Shuman S
    Nucleic Acids Res; 1997 Aug; 25(15):3001-8. PubMed ID: 9224599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia virus DNA topoisomerase: a model eukaryotic type IB enzyme.
    Shuman S
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):321-37. PubMed ID: 9748643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of 26 residues of vaccinia DNA topoisomerase identifies Ser-204 as important for DNA binding and cleavage.
    Wang LK; Wittschieben J; Shuman S
    Biochemistry; 1997 Jul; 36(26):7944-50. PubMed ID: 9201940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpolar nucleobase analogs illuminate requirements for site-specific DNA cleavage by vaccinia topoisomerase.
    Yakovleva L; Lai J; Kool ET; Shuman S
    J Biol Chem; 2006 Nov; 281(47):35914-21. PubMed ID: 17005552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of 39 residues of vaccinia DNA topoisomerase identifies Lys-220, Arg-223, and Asn-228 as important for covalent catalysis.
    Cheng C; Wang LK; Sekiguchi J; Shuman S
    J Biol Chem; 1997 Mar; 272(13):8263-9. PubMed ID: 9079646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A poxvirus-like type IB topoisomerase family in bacteria.
    Krogh BO; Shuman S
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1853-8. PubMed ID: 11830640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.
    Wang LK; Shuman S
    Biochemistry; 1997 Apr; 36(13):3909-16. PubMed ID: 9092821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogues of vaccinia virus DNA topoisomerase I modified at the active site tyrosine.
    Gao R; Zhang Y; Choudhury AK; Dedkova LM; Hecht SM
    J Am Chem Soc; 2005 Mar; 127(10):3321-31. PubMed ID: 15755148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine 265 is important for covalent catalysis by vaccinia topoisomerase and is conserved in all eukaryotic type I enzymes.
    Petersen BO; Shuman S
    J Biol Chem; 1997 Feb; 272(7):3891-6. PubMed ID: 9020090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a bacterial type IB DNA topoisomerase reveals a preassembled active site in the absence of DNA.
    Patel A; Shuman S; Mondragón A
    J Biol Chem; 2006 Mar; 281(9):6030-7. PubMed ID: 16368685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.
    Shuman S; Kane EM; Morham SG
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9793-7. PubMed ID: 2557629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic mechanism of DNA topoisomerase IB.
    Krogh BO; Shuman S
    Mol Cell; 2000 Jun; 5(6):1035-41. PubMed ID: 10911997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote phosphate contacts trigger assembly of the active site of DNA topoisomerase IB.
    Tian L; Claeboe CD; Hecht SM; Shuman S
    Structure; 2004 Jan; 12(1):31-40. PubMed ID: 14725763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of vaccinia DNA topoisomerase defines amino acid residues essential for covalent catalysis.
    Wittschieben J; Shuman S
    J Biol Chem; 1994 Nov; 269(47):29978-83. PubMed ID: 7961997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic residues of the telomere resolvase ResT: a pattern similar to, but distinct from, tyrosine recombinases and type IB topoisomerases.
    Deneke J; Burgin AB; Wilson SL; Chaconas G
    J Biol Chem; 2004 Dec; 279(51):53699-706. PubMed ID: 15471873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases.
    Cheng C; Kussie P; Pavletich N; Shuman S
    Cell; 1998 Mar; 92(6):841-50. PubMed ID: 9529259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB.
    Reed B; Yakovleva L; Shuman S; Ghose R
    Biochemistry; 2017 Jul; 56(26):3307-3317. PubMed ID: 28570045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.